Welcome to the ESPID 2022 Meeting Calendar
The Meeting will officially run on Eastern European Summer Time (Greece Time, CEST+1, GMT+2)
To convert the meeting times to your local time Click Here
Session Description:
This symposium will focus on the epidemiology and public health impact of noninvasive pneumococcal disease in children and considerations to optimize prevention with the introduction of new pneumococcal conjugate vaccines.
Session Description:
This symposium aims to highlight recent therapeutic advances in the management of bacterial infections in paediatric patients. Throughout this pragmatic session, through patient case studies, our expert faculty will highlight the urgent need for safe and effective treatment options to address the current and anticipated burden of bacterial disease. While one speaker will address the growing threat of multidrug-resistant (MDR) Gram-negative infections and explore how alternative treatment options could improve patient outcomes, another expert will challenge the current standard of care used to treat community-acquired pneumonia (CAP) and complicated skin and soft tissue infections (cSSTIs), reviewing the potential role of therapeutic advances in meeting a clinical unmet need. The symposium will close with a panel discussion, where our esteemed faculty will discuss topics including the need for right-first-time treatment decisions, risk factors for infection in paediatric patients and the role of the multidisciplinary team in effective patient management. Additionally, there will be an opportunity for the audience to engage with the faculty by submitting pressing questions during the discussion for the panel to address.
Session Description:
The Neisseria symposium will provide an overview of MenB vaccination in infants and adolescents as well as novel, emerging vaccine strategies. Prof. Muhamed-Kheir Taha will cover real-world evidence for 4CMenB in infants and important factors in driving recommendations. Prof. Lee Harrison will discuss the evidence and rationale for adolescent vaccination programmes. Lastly, Dr. Rino Rappuoli will highlight new scientific innovations in the field of Neisseria disease prevention.
Session Description:
This sponsored session will focus on raising awareness of the impact of childhood invasive meningococcal disease (IMD) and advances in preventative strategies. The distinguished faculty will provide expert perspectives on key challenges as well as discuss the most important unmet needs which still need to be addressed to reduce the burden of disease in infants, children and adolescents, and the impact on their families. This satellite symposium specifically intended for healthcare professionals (HCPs) is sponsored by Sanofi on the occasion of the 40th Annual Meeting of the European Society for Paediatric Infectious Diseases, 9-13 May 2021. Individual medicinal products that may be referred to during this session may not be authorised/licensed or available in all countries. Content, where applicable, is based on the European Summary of Product Characteristics (SmPC). Please consult prescribing information in your country of practice, current to the date of viewing this session, as information may vary from country-to-country.
Session Description:
This symposium will provide an overview of the recent changes in the tick-borne disease landscape as a result of the pandemic, including tick-borne encephalitis (TBE) and Lyme borreliosis. The session will also cover key neurological symptoms of these diseases, diagnosis and treatment, before exploring the impact of these diseases on children as well as how symptoms may vary compared to adults.
Session Description:
TBA
Session Description:
Satellite Symposium aims to share information and data on burden of pediatric diseases, impact of vaccination and criteria for implementing and executing successful immunization programs. The symposium will feature presentation, followed by a question and answers section with panel members.